Percutaneous Pulmonary Artery Denervation (PADN) for the Treatment of Pulmonary Hypertension After Transcatheter Mitral Valve Edge-to-Edge Repair (M-TEER): A Prospective Cohort Study

NCT07662655 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Hypertension
Pulmonary Hypertension Associated With HFpEF

Interventions

DEVICE: Percutaneous Pulmonary Artery Denervation (PADN)
DRUG: Control group (receiving standard medical therapy alone)

Sponsor

Xiamen Cardiovascular Hospital, Xiamen University